Laryngopharyngeal Reflux Disease: Microbial Signatures and Their Associations With Clinical and Digestive Enzyme Profiles

OBJECTIVE: To characterize the salivary microbiome of patients with laryngopharyngeal reflux disease (LPRD) and investigate its associations with clinical presentation and salivary gastroduodenal enzymes. STUDY DESIGN: Prospective controlled study. SETTING: University Hospital. METHODS: Saliva samples from patients with LPRD at the 24-hour hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing and asymptomatic individuals were consecutively collected for analyzing digestive enzyme/biomarker (pepsin, elastase, bile salts, cholesterol, trypsin) and microbiome features (16S rRNA IlluminaMiSeq). Pretreatment to posttreatment symptoms and findings were evaluated with reflux symptom score and reflux sign assessment. Association between microbiome abundance, enzyme concentration, and baseline and post-treatment clinical findings were assessed. RESULTS: Sixty-seven LPRD patients (40 females [59.7%]) and 44 controls (26 females [59.1%]) completed the evaluations. LPRD patients demonstrated significantly higher concentrations of elastase, higher salivary pH, and lower levels of cholesterol compared to controls. The comparative analysis of salivary microbiota between LPRD patients and controls demonstrated significant taxonomic-level alterations in alpha diversity (reduced Shannon index at family and genus levels in LPRD, P < .006) and beta diversity (distinct community composition by UniFrac metrics, PERMANOVA, P ≤ .005), with differential abundance of key taxa including a modulation of Streptococcus species, elevated Actinomyces and Abiotrophia, and depleted Oribacterium and Eubacterium nodatum group in LPRD patients compared to controls. Elastase, trypsin, and bile salts reported significant association with relative abundance of some bacteria. CONCLUSION: This preliminary study supports that LPRD patients exhibit distinct microbial signatures compared to asymptomatic subjects, characterized by reduced diversity at specific taxonomic levels, subtle shifts in community membership, and differential abundance of some key genera.

Authors

Institutions

Publication Details

Journal
Otolaryngology
Published
2026-09-01
DOI
https://doi.org/10.1002/ohn.70421
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Laryngopharyngeal Reflux Disease: Microbial Signatures and Their Associations With Clinical and Digestive Enzyme Profiles

Jennifer Aoun, Jerome Rene Lechien, Alexandra Rodriguez, Anne Trelcat et al.
Otolaryngology
Gastroesophageal reflux and treatments
article

Laryngopharyngeal Reflux Disease: Microbial Signatures and Their Associations With Clinical and Digestive Enzyme Profiles

Jennifer Aoun, Jerome Rene Lechien, Alexandra Rodriguez, Anne Trelcat, Stéphane Hans, Vinciane Muls, Didier Dequanter, Sven Saussez, Nathalie De Vos, Giovanni Briganti, Patricia B. Rodrigues, Amandine Everard
article en

Abstract

OBJECTIVE: To characterize the salivary microbiome of patients with laryngopharyngeal reflux disease (LPRD) and investigate its associations with clinical presentation and salivary gastroduodenal enzymes. STUDY DESIGN: Prospective controlled study. SETTING: University Hospital. METHODS: Saliva samples from patients with LPRD at the 24-hour hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing and asymptomatic individuals were consecutively collected for analyzing digestive enzyme/biomarker (pepsin, elastase, bile salts, cholesterol, trypsin) and microbiome features (16S rRNA IlluminaMiSeq). Pretreatment to posttreatment symptoms and findings were evaluated with reflux symptom score and reflux sign assessment. Association between microbiome abundance, enzyme concentration, and baseline and post-treatment clinical findings were assessed. RESULTS: Sixty-seven LPRD patients (40 females [59.7%]) and 44 controls (26 females [59.1%]) completed the evaluations. LPRD patients demonstrated significantly higher concentrations of elastase, higher salivary pH, and lower levels of cholesterol compared to controls. The comparative analysis of salivary microbiota between LPRD patients and controls demonstrated significant taxonomic-level alterations in alpha diversity (reduced Shannon index at family and genus levels in LPRD, P < .006) and beta diversity (distinct community composition by UniFrac metrics, PERMANOVA, P ≤ .005), with differential abundance of key taxa including a modulation of Streptococcus species, elevated Actinomyces and Abiotrophia, and depleted Oribacterium and Eubacterium nodatum group in LPRD patients compared to controls. Elastase, trypsin, and bile salts reported significant association with relative abundance of some bacteria. CONCLUSION: This preliminary study supports that LPRD patients exhibit distinct microbial signatures compared to asymptomatic subjects, characterized by reduced diversity at specific taxonomic levels, subtle shifts in community membership, and differential abundance of some key genera.

Otolaryngology
University of Mons (BE), IMT Atlantique (FR), Walloon Excellence in Lifesciences and Biotechnology (BE), Centre Hospitalier Universitaire de Saint-Pierre (BE), UCLouvain (BE)
Université Catholique de Louvain, Fonds De La Recherche Scientifique - FNRS, Koning Boudewijnstichting, Walloon excellence in life sciences and biotechnology
Openalex Percentile: Top 9%
Gastroesophageal reflux and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.